Navigation Links
First 90 Days After Stopping Plavix Most Dangerous

Study finds highest risk of adverse events for heart patients is in early period

TUESDAY, Feb. 5 (HealthDay News) -- New research finds that the first three months after heart patients stop taking the clot-preventing drug Plavix are the most dangerous.

"This is the first study to make this observation," said Dr. P. Michael Ho, a cardiologist at the Denver VA Medical Center and lead author of a report in the Feb. 6 issue of the Journal of the American Medical Association. "We need additional studies to confirm it, and see whether and why there is an increase in adverse events after stopping."

The study does not address the issue of how long Plavix (clopidogrel) may safely be taken, said Ho, who is an assistant professor of medicine at the University of Colorado. The current recommendation is that it should be used for nine months after a heart attack and 12 months after a stent is implanted to help an artery stay open.

"We looked at people who took different lengths of clopidogrel treatment," Ho said. "We found a twofold increase in risk in the 90-day period after stopping for those who [took it] less than six months or greater than nine months. For those who took clopidogrel longer than 12 months or 15 months, we could not calculate the increased risk because we did not have enough patients."

Ho and his colleagues assessed the incidence and timing of death or acute heart attacks in 3,137 people discharged from 127 VA hospitals who were taking Plavix after an acute coronary syndrome event, such as a heart attack. The average time of Plavix treatment was 302 days.

Analysis found the incidence of adverse events was higher in the 90 days after the medication was stopped than in the 91 to 180 days after cessation.

"This is going to get a lot of attention, both from doctors and the medical community at large, because clopidogrel is such a widely used drug," said Dr. Deepak Bhatt, associate director of the Cleveland Clinic Cardiovascular Coordinating Center.

The finding "follows common sense, but no one has actually shown this before in a large group of patients," Bhatt said.

The results appear to support the view that longer therapy with clopidogrel is better but does not completely answer that question, he said. "The very necessary next step is to figure out whether longer duration is better in a randomized, controlled trial."

Such a controlled trial would meet the gold standard for medical research. The newly reported study was observational, Ho noted, meaning that it examined what was happening in medical practice without attempting to single out factors affecting the results.

A decision on whether or when to stop clopidogrel treatment must be made on a case-by-case basis, Ho said. "The final decision should be left to provider and patient," he said. "They have to weigh the risk of discontinuing clopidogrel against the risk of abnormal bleeding if it is continued. The clinician needs to weigh the risk and benefits for each individual patient."

Those making the decision should remember that the risk found in the study was "relatively small," Ho said. Among the more than 3,000 cases studied, there were 163 adverse events in the 90 days after drug treatment stopped, 57 in the following 90 days, and 26 in the third 90-day period.

More information

Learn about the benefits and possible hazards of using clopidogrel from the U.S. Library of Medicine.

SOURCES: P. Michael Ho, M.D., Ph.D, cardiologist, Denver VA Medical Center; Deepak Bhatt, M.D., associate director, Cleveland Clinic Cardiovascular Coordinating Center; Feb. 6, 2008, Journal of the American Medical Association

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. First biomarker discovered that predicts prostate cancer outcome
2. FDA Approves First Anti-Psychotic for Kids
3. Single-incision belly-button surgery to remove kidney performed first at UT Southwestern
4. First study examines newly-licensed RN work attitudes and intentions
5. Glades General Hospital First in Palm Beach County to Provide On-Site Electronic Birth Registration
6. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
7. Father and Daughter From Tanzania Receive Their First Medical Examination in Newport Beach
8. High and mighty: first common height gene identified by researchers behind obesity gene finding
9. APA Comments on FDAs First Approval of Medication to Treat Pediatric Schizophrenia and Bipolar Disorder
10. TriWest Creates First-of-its-Kind Partnership to Offer Military Leaders With Grief Support Program
11. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
Post Your Comments:
Related Image:
First 90 Days After Stopping Plavix Most Dangerous
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet ... product that was developed to enhance the health of felines. The formula is all-natural ... two main herbs in the PawPaws Cat Kidney Support Supplement Soft Chews ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes ... important health care topics including advance care planning, healthcare costs and patient and ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, ... Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms ... Final Cut Pro X . Simply select a ProHand generator and drag it above ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published ... unfamiliar with. The article goes on to state that individuals are now more comfortable ... less common operations such as calf and cheek reduction. The Los Angeles area medical ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... According to a new market ... Needles, Safety Pen Needles), Needle Length (4mm, 5mm, 6mm, ... of Purchase (Retail, Non-Retail) - Trends & Global Forecasts ... market for the forecast period of 2016 to 2021. ... by 2021 from USD 1.65 Billion in 2016, growing ...
(Date:6/23/2016)... HOUSTON , June 23, 2016  MedSource ... platform as its e-clinical software solution of choice.  ... the best possible value to their clients by ... nowEDC.  The preferred relationship establishes nowEDC as the ... pricing for MedSource,s full-service clients.  "nowEDC has long ...
(Date:6/23/2016)... , June 23, 2016  In a startling report released today, ... their residents by lacking a comprehensive, proven plan to eliminate prescription ... definitive ranking of how states are tackling the worst drug crisis ... four states – Kentucky , New ... Vermont . Of the 28 failing states, three – ...
Breaking Medicine Technology: